Abstracts

Citation

Francesca Aweeka, Pharm.D., Patricia S. Lizak, B.S., Lisa M. Frenkel, M.D., Heather D. Watts, M.D., James McNamara, M.D., Jane Hitti, M.D., M.P.H. Nevirapine Pharmacokinetics During 2nd and 3rd Trimester Pregnancy and Post-Partum; PACTG 1022 Study.

Citation

Nevirapine vs Kaletra for treatment of single dose Nevirapine-exposed HIV-infected infants: preliminary results from IMPAACT P1060. Presented at: 5th IAS Conf on HIV Pathogenesis, TX & Prevention.

Citation

Akihiko Saitoh, M.D., S. Sandall, Kumud K. Singh, Christine Powell, M.A., Terence Fenton, Ed.D., Courtney V. Fletcher, Pharm.D., Karen Hsia, Ph.D., Stephen A. Spector, M.D. New Thymic Emigrants as Determined by T-cell Receptor Excision Circles (TREC) are Associated with the CD4+ Lymphocytes and Intracellular DNA Levels in HIV-1 infected Children Before and During Sustained, Undetectable Plasma HIV-1 RNA.

Citation

Li Yin, Carina Rodriguez, Jiqiang Yao, Kaifen Chang, Manju Karki, John Sleasman, Maureen Goodenow. NextGen sequencing defines response to H1N1 vaccination in HIV-infected individuals. Presented at: CROI 2016; 2016 Feb 25.

Citation

William T. Shearer, M.D., Ph.D., Jaime G. Deville, M.D., Pearl Samson, M.S., John ( Jack ) Moye, Jr., M.D., Joseph A. Church, M.D., Hans ML Spiegel, M.D., Ph.D., Terence Fenton, Ed.D., Elizabeth (Betsy) Smith, M.D., Bobbie L. Graham, B.S., Courtney V. Fletcher, Pharm.D. Non-linear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 observed in HIV-1-infected children. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

William T. Shearer, M.D., Ph.D., Howard Max Rosenblatt, M.D., Stephen A. Spector, M.D., E. Richard Stiehm, M.D., Diane W. Wara, M.D., Steven D. Douglas, M.D., Katherine Luzuriaga, M.D., Elizabeth (Betsy) J. McFarland, M.D., Ram Yogev, M.D., Mobeen H. Rathore, M.D., Wende Levy, R.N., M.S., Bobbie L. Graham, B.S., Rebecca Oyomopito, M.S., Rebecca S. Gelman, Ph.D. Normal distribution of peripheral blood mononuclear cell (PBMC) subsets from birth to 18 years: the NIH NIAID DAIDS Pediatric AIDS Clinical Trial Group P-1009 Protocol (Abstract 813). Presented at: 60th American Academy of Allergy, Asthma & Immuno Annual Mtg.

Citation

J.A. Shepherd, B. Fan, C. Powers, L. Stranix-Chibanda, M.G. Fowler, L.A. DiMeglio, C. Mukwasi, K. George , G. Siberry. Novel “3-6” infant DXA scanning and analysis protocols to isolate movement and other artifacts.

Citation

Julie A E Nelson, Ali Fokar, Michael G Hudgens, Kara J Comliment, Gerald Tegha, Deborah Kamwendo, Athena P Kourtis, Denise J Jamieson, Charles Van Der Horst, Susan A Fiscus. NVP Resistance in Infants Infected by HIV-1 via Breastfeeding in the BAN Study. Presented at: CROI 2015; 2015 Feb 25.

Citation

Warren A. Andiman, M.D., Miriam Chernoff, Ph.D., Charles Debeaux Mitchell, M.D., James M. Oleske, M.D., Philimon Gona, Ph.D., Murli Purswani, M.D., Jennifer R. Tappenden, B.A., George Seage, III, Sc.D., M.P.H. Occurrence of renal diseases/laboratory abnormalities among HIV-infected children enrolled in PACTG 219/219C - iDACS 617. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

Omitting NRTIs from ARV regimens is not inferior to adding NRTIs in treatment experienced HIV+ subjects failing a PI regimen: The ACTG OPTIONS study. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.